Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT05301140Recruiting

Vivistim Registry for Paired VNS Therapy (GRASP)

Role: lead

NCT05601661Not ApplicableCompleted

Safety and Feasibility of Paired Vagus Nerve Stimulation With Rehabilitation for Improving Upper Extremity Function in People With Cervical Spinal Cord Injury

Role: collaborator

NCT05691023Active Not Recruiting

VNS-REHAB At-Home - Post-Market Study for Using the Vivistim System® at Home

Role: lead

NCT02243020Not ApplicableCompleted

VNS During Rehabilitation for Improved Upper Limb Motor Function After Stroke

Role: lead

NCT03131960Not ApplicableCompleted

Pivotal Study of VNS During Rehab After Stroke (VNS-REHAB)

Role: lead

NCT01962558Not ApplicableCompleted

Vagus Nerve Stimulation (VNS) Paired With Tones for Tinnitus

Role: lead

NCT01253616Not ApplicableCompleted

Proof-of-Concept Study Assessing VNS Paired With Tones for Tinnitus

Role: lead

NCT01669161Not ApplicableCompleted

Paired Vagus Nerve Stimulation (VNS) With Rehabilitation for Upper Limb Function Improvement After Stroke

Role: lead

All 8 trials loaded